Sabra Health Care REIT Inc. (NASDAQ: SBRA) stock fell -2.42% on Thursday to $10.48 against a previous-day closing price of $10.74. With 1.78 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.11 million shares. During the session, the REIT – Healthcare Facilities company that operates in wider Real Estate sector, reached to the highest price of $10.76 whereas the lowest price it dropped to was $10.45. The 52-week range on SBRA shows that it touched its highest point at $16.41 and its lowest point at $10.08 during that stretch. It currently has a 1-year price target of $12.69. With its current market cap of 2.47 billion, SBRA has annualized dividend of $1.20 while the current yield stands at 11.45%. Beta for the stock currently stands at 1.30.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SBRA was down-trending over the past week, with a drop of -5.59%, but this was down by -4.12% over a month. Three-month performance dropped to -14.10% while six-month performance fell -16.56%. The stock lost -20.71% in the past year, while it has lost -15.69% so far this year. A look at the trailing 12-month EPS for SBRA yields -0.55 with Next year EPS estimates of 0.44. For the next quarter, that number is 0.10. This implies an EPS growth rate of 35.00% for this year and 80.58% for next year. EPS is expected to grow by 7.30% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -17.50%.
Float and Shares Shorts:
At present, 231.16 million SBRA shares are outstanding with a float of 228.02 million shares on hand for trading. On May 14, 2023, short shares totaled 10.27 million, which was 4.44% higher than short shares on Apr 13, 2023. In addition to Mr. Richard K. Matros as the firm’s Chairman, Pres & CEO, Mr. Michael Lourenco Costa serves as its Exec. VP, CFO, Principal Accounting Officer & Sec.
Institutional Ownership:
Through their ownership of 90.59% of SBRA’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 53.81% of SBRA, in contrast to 44.08% held by mutual funds. Shares owned by individuals account for 1.71%. As the largest shareholder in SBRA with 15.12% of the stake, The Vanguard Group, Inc. holds 34,946,751 shares worth 34,946,751. A second-largest stockholder of SBRA, BlackRock Fund Advisors, holds 28,084,504 shares, controlling over 12.15% of the firm’s shares. Principal Global Investors LLC is the third largest shareholder in SBRA, holding 15,648,560 shares or 6.77% stake. With a 4.39% stake in SBRA, the Vanguard Real Estate Index Fund is the largest stakeholder. A total of 10,150,539 shares are owned by the mutual fund manager. The Vanguard Total Stock Market ETF, which owns about 3.13% of SBRA stock, is the second-largest Mutual Fund holder. It holds 7,225,944 shares valued at 82.38 million. iShares Core S&P Mid Cap ETF holds 3.12% of the stake in SBRA, owning 7,207,694 shares worth 82.17 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, SBRA reported revenue of $155.96M and operating income of $63.53M. The EBITDA in the recently reported quarter was $104.01M and diluted EPS was $0.07.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SBRA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With SBRA analysts setting a high price target of $15.00 and a low target of $11.00, the average target price over the next 12 months is $12.58. Based on these targets, SBRA could surge 43.13% to reach the target high and rise by 4.96% to reach the target low. Reaching the average price target will result in a growth of 20.04% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Dividends & Yield:
In terms of dividends, SBRA has a current ratio of $1.2, which is $1.2 over the trailing 12-months, while a dividend of $1.49 is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and SBRA currently yields $11.45. In the past year, SBRA’s dividend yield has been $11.45, but when looking at the stock over the past five years, its yield has been $9.04. Accordingly, SBRA has a current buyback yield of $0.12. This was $0.12 for the TTM.
Summary of Insider Activity:
Insiders traded SBRA stock several times over the past three months with 11 Buys and 1 Sells. In these transactions, 38,733 shares were bought while 5,151 shares were sold. The number of buy transactions has increased to 56 while that of sell transactions has risen to 7 over the past year. The total number of shares bought during that period was 515,325 while 123,277 shares were sold.
